Tool assesses risk of future obesity in newborns

Article

Researchers have developed an algorithm that uses traditional risk factors to predict whether a newborn will develop obesity as a child.

Recent Videos
Tanya Altmann, MD, discusses the growing issue of childhood obesity in the United States and the benefits of new weight management medications.
Tina Tan, MD
Nicole Peña Sahdala, MD, internist, gastroenterologist specialist in bariatric endoscopy, ABIM certified | Image Credit: Provided
Related Content
GLP-1 receptor agonists linked to reduced suicidal ideation in adolescents with obesity | Image Credit: © 9dreamstudio - © 9dreamstudio - stock.adobe.com.

GLP-1 receptor agonist treatment linked to reduced suicidal ideation in adolescents with obesity

Joshua Fitch, Senior Editor
October 16th 2024
Article

GLP-1 receptor agonists are increasingly being used to treat obesity in adolescents.

Addressing atypical anorexia: Part 1

Addressing atypical anorexia: Part 1

Miranda Hester
January 28th 2022
Podcast

Contemporary Pediatrics sat down with Dr. Erin Harrop, an assistant professor at University of Denver in Colorado and a licensed medical social worker to talk about atypical anorexia nervosa, including diagnostic challenges.

Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN

Technology: How far we have come and how far can we go?

Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN
September 23rd 2024
Article

In her September 2024 article, Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, highlights the potential of digital health tools to improve care for pediatric mental health, obesity, and medically complex conditions.

Low-food access in early life associated with higher subsequent child BMI, obesity risk | Image Credit: © Kwangmoozaa - © Kwangmoozaa - stock.adobe.com.

Low-food access in early life associated with higher subsequent child BMI, obesity risk

Joshua Fitch, Senior Editor
September 18th 2024
Article

Investigators found the association for higher BMI, increased obesity risk, and increased severe obesity risk.

FDA accepts setmelanotide NDA for obesity in patients down to 2 years | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.

FDA accepts setmelanotide NDA for obesity in patients down to 2 years

Joshua Fitch, Senior Editor
August 26th 2024
Article

Following the FDA's acceptance of the NDA, a PDUFA date of December 26, 2024 has been set for setmelanotide in patients as young as 2 years of age.

Image Credit: © Artur - © Artur - stock.adobe.com.

Weekly review: Digital technologies for mental health, obesity, and more

Joshua Fitch, Senior Editor
August 12th 2024
Article

Get caught up with our journal! Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

© 2024 MJH Life Sciences

All rights reserved.